TIAA CREF Investment Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-81,150
Closed -$142K 3138
2016
Q4
$142K Hold
81,150
﹤0.01% 3064
2016
Q3
$219 Hold
81,150
﹤0.01% 3042
2016
Q2
$192K Sell
81,150
-102,817
-56% -$284K ﹤0.01% 3096
2016
Q1
$594K Buy
183,967
+28,250
+18% +$104K ﹤0.01% 2736
2015
Q4
$746K Buy
155,717
+4,894
+3% +$27.7K ﹤0.01% 2745
2015
Q3
$839K Hold
150,823
﹤0.01% 2672
2015
Q2
$1.2M Buy
150,823
+10,000
+7% +$85.9K ﹤0.01% 2609
2015
Q1
$1.48M Sell
140,823
-3,298
-2% -$45.1K ﹤0.01% 2408
2014
Q4
$1.73M Sell
144,121
-9,130
-6% -$139K ﹤0.01% 2344
2014
Q3
$2.62M Sell
153,251
-4,179
-3% -$60.7K ﹤0.01% 2059
2014
Q2
$1.9M Buy
157,430
+34,425
+28% +$326K ﹤0.01% 2329
2014
Q1
$1.04M Buy
123,005
+8,320
+7% +$67.1K ﹤0.01% 2627
2013
Q4
$675K Sell
114,685
-25,803
-18% -$133K ﹤0.01% 2872
2013
Q3
$763K Sell
140,488
-36,676
-21% -$176K ﹤0.01% 2777
2013
Q2
$719K Buy
+177,164
New +$831K ﹤0.01% 2787

Other funds holding BDSI

TIAA CREF Investment Management's BDSI Position: Q1 2017 in Review

TIAA CREF Investment Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2017, closing a stake of 81,150 shares — an estimated $142K sold.

TIAA CREF Investment Management first reported a position in BDSI in Q2 2013 and held it in 15 quarters. The position peaked at $2.62M in Q3 2014. 63 funds tracked by Wall St. Rank hold BDSI as of Q1 2017.

  • TIAA CREF Investment Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 81,150 BioDelivery Sciences International, Inc. shares in Q1 2017, an estimated $142K.
  • TIAA CREF Investment Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 15 quarters.
  • TIAA CREF Investment Management's BioDelivery Sciences International, Inc. position peaked at $2.62M in Q3 2014.
  • 63 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2017.

Based on TIAA CREF Investment Management's 13F filing for Q1 2017, filed 11 May 2017.